ResMed AirSense 11 Elite CPAP Machine

The ResMed AirSense™ 11 Elite is a premium fixed-pressure device with integrated heated humidifier, wireless connectivity, advanced event detection and support features.

Key Features of the AirSense 11

Personal Therapy Assistant in myAir™ guides patients through equipment setup and acclimation by providing interactive voice-guided video instructions.

Care Check-In asks time-based check-in questions throughout the first month of therapy and provides tailored coaching and support to help troubleshoot common therapy issues.

Availability of over-the-air software upgrade capability provides the opportunity to directly receive maintenance and feature updates.

An easy-to-use touchscreen makes navigating AirSense 11 settings simple and intuitive.

Advanced event detection identifies central sleep apnea, respiratory effort–related arousal and Cheyne-Stokes respiration events to provide treating physicians valuable insight into the continued health of your patients.

Using AirView™, you can access nightly therapy data, troubleshoot remotely (using the Remote Assist feature) and change device settings remotely. If patients opt-in, data from their Care Check-In responses will be available in AirView, which can provide a deeper understanding of therapy progress.

Simple Start/Stop button makes it easy to turn therapy on and off with a single tap.

The quiet Easy-Breathe motor makes for a peaceful environment for the patient and their bed partner.

Built-in ambient light sensor adjusts brightness of the screen based on the light in the room and turns off automatically.

Integrated heated humidifier can be controlled manually or automatically with the Climate Control feature.

Supported by Air Solutions
AirSense 11 CPAP is supported by Air Solutions, a comprehensive set of tools proven to help patients acclimate and adhere to therapy – such as ResMed AirView, our remote monitoring platform, and myAir, our patient engagement app. 6 When used together, these digital health technologies have been shown to increase 90-day CMS-defined therapy compliance to 87% vs 70% monitoring with AirView alone. 7 8 myAir users also consistently slept one hour longer on average each night during the first 90 days of therapy than other CPAP users.